405 related articles for article (PubMed ID: 18333357)
21. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
Al-Bahrani AI; Bakhiet CS; Bayoumi RA; Al-Yahyaee SA
Diabetes Res Clin Pract; 2005 Jul; 69(1):44-51. PubMed ID: 15904989
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
[TBL] [Abstract][Full Text] [Related]
23. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
[TBL] [Abstract][Full Text] [Related]
24. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
[TBL] [Abstract][Full Text] [Related]
25. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
26. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment.
Andrikoula M; McDowell IF
Diabetes Obes Metab; 2008 Apr; 10(4):271-8. PubMed ID: 18333887
[TBL] [Abstract][Full Text] [Related]
27. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
Lind L; Vessby B; Sundström J
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
[TBL] [Abstract][Full Text] [Related]
28. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.
Walldius G; Jungner I
Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):565-71. PubMed ID: 17631989
[TBL] [Abstract][Full Text] [Related]
29. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
30. [An experience of lipoprotein (a) dosage in a Moroccan population of 184 subjects].
Fellat S; Lahfidi K; Sraïri JE; el Haïtem N; Mesbahi R; Ghanam R; Benomar M
Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1371-6. PubMed ID: 9539837
[TBL] [Abstract][Full Text] [Related]
31. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
Dirisamer A; Stadler A; Bucek RA; Widhalm K
Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
[TBL] [Abstract][Full Text] [Related]
32. Cord blood lipid profile and associated factors: baseline data of a birth cohort study.
Kelishadi R; Badiee Z; Adeli K
Paediatr Perinat Epidemiol; 2007 Nov; 21(6):518-24. PubMed ID: 17937737
[TBL] [Abstract][Full Text] [Related]
33. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
34. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
36. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
Holme I; Høstmark AT; Anderssen SA
J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
[TBL] [Abstract][Full Text] [Related]
37. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
38. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects.
Kostapanos MS; Christogiannis LG; Bika E; Bairaktari ET; Goudevenos JA; Elisaf MS; Milionis HJ
J Stroke Cerebrovasc Dis; 2010; 19(6):497-502. PubMed ID: 20538481
[TBL] [Abstract][Full Text] [Related]
40. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
Yanni AE; Perrea DN; Yatzidis HA
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
